1. Home
  2. HUBC vs PPBT Comparison

HUBC vs PPBT Comparison

Compare HUBC & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HUBC

Hub Cyber Security Ltd.

HOLD

Current Price

$0.46

Market Cap

6.6M

Sector

N/A

ML Signal

HOLD

Logo Purple Biotech Ltd.

PPBT

Purple Biotech Ltd.

N/A

Current Price

$1.79

Market Cap

2.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HUBC
PPBT
Founded
2017
2010
Country
Israel
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6M
2.4M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
HUBC
PPBT
Price
$0.46
$1.79
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$30.00
AVG Volume (30 Days)
159.2K
2.0M
Earning Date
05-01-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$0.41
52 Week High
$7.00
$5.18

Technical Indicators

Market Signals
Indicator
HUBC
PPBT
Relative Strength Index (RSI) 21.99 54.90
Support Level $0.30 $1.35
Resistance Level $0.50 $1.85
Average True Range (ATR) 0.05 0.22
MACD -0.01 0.02
Stochastic Oscillator 0.66 26.79

Price Performance

Historical Comparison
HUBC
PPBT

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in developing reliable quality assurance systems that support process and product enhancement and also operates in the industry of secured data fabric. The company serves various organizations and institutions operating in the security, electronics, aviation, telecommunications, and banking. The company has two operating segments: Product and Technology Segment and Professional Services Segment. The majority of revenue comes from the professional services segment, which provides data and cybersecurity and system security and reliability solutions and related services such as consulting, planning, integrating and ongoing servicing of cybersecurity, risk management, reliability and security projects and fully managed corporate cybersecurity services.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.

Share on Social Networks: